XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Balance at beginning of period (in shares) at Dec. 31, 2021   177,551,000        
Balance at beginning of period at Dec. 31, 2021 $ 13,245 $ 2 $ 14,084 $ (1,998)   $ 1,157
Increase (Decrease) in Stockholders' Equity            
Unit-based compensation 3         3
Distribution equivalent rights payments (1)         (1)
Stock-based compensation 16   16      
Cash paid for tax withholding on vested equity awards (15)   (15)      
Repurchased shares for share buyback program (in Shares)   (58,000)        
Repurchased shares under buyback program (7)   (7)      
Repurchased units under buyback programs (42)         (42)
Distributions to non-controlling interest (47)         (47)
Dividend paid (107)     (107)    
Exercise of stock options and issuance of restricted stock units and awards (in Shares)   58,000        
Exercise of stock options and issuance of restricted stock units and awards 1   1      
Change in ownership of consolidated subsidiaries, net 3   (12)     15
Net income (loss) 803     779   24
Balance at end of period (in shares) at Mar. 31, 2022   177,551,000        
Balance at end of period at Mar. 31, 2022 13,852 $ 2 14,067 (1,326)   1,109
Balance at beginning of period (in shares) at Dec. 31, 2021   177,551,000        
Balance at beginning of period at Dec. 31, 2021 13,245 $ 2 14,084 (1,998)   1,157
Increase (Decrease) in Stockholders' Equity            
Net income (loss) 2,264          
Balance at end of period (in shares) at Jun. 30, 2022   175,201,000        
Balance at end of period at Jun. 30, 2022 14,390 $ 2 13,772 (458)   1,074
Balance at beginning of period (in shares) at Mar. 31, 2022   177,551,000        
Balance at beginning of period at Mar. 31, 2022 13,852 $ 2 14,067 (1,326)   1,109
Increase (Decrease) in Stockholders' Equity            
Unit-based compensation 3         3
Distribution equivalent rights payments (7)     (7)    
Stock-based compensation 17   17      
Cash paid for tax withholding on vested equity awards (3)         (3)
Repurchased shares for share buyback program (in Shares)   (2,369,000)        
Repurchased shares under buyback program (303)   (303)      
Repurchased units under buyback programs (29)         (29)
Distributions to non-controlling interest (63)         (63)
Dividend paid (541)     (541)    
Exercise of stock options and issuance of restricted stock units and awards (in Shares)   19,000        
Change in ownership of consolidated subsidiaries, net 3   (9)     12
Net income (loss) 1,461     1,416   45
Balance at end of period (in shares) at Jun. 30, 2022   175,201,000        
Balance at end of period at Jun. 30, 2022 $ 14,390 $ 2 13,772 (458)   1,074
Balance at beginning of period (in shares) at Dec. 31, 2022 179,840,797 179,841,000        
Balance at beginning of period at Dec. 31, 2022 $ 15,690 $ 2 14,213 801 $ (7) 681
Increase (Decrease) in Stockholders' Equity            
Unit-based compensation 1         1
Distribution equivalent rights payments (4)     (4)    
Stock-based compensation 15   15      
Cash paid for tax withholding on vested equity awards (in shares)   (119,000)        
Cash paid for tax withholding on vested equity awards (18)   (18)      
Repurchased shares for share buyback program (in Shares)   (2,531,000)        
Repurchased shares under buyback program (332)   (332)      
Repurchased units under buyback programs (34)         (34)
Common units issued for acquisitions (in Shares)   4,330,000        
Common units for acquisitions 633   633      
Distributions to non-controlling interest (34)         (34)
Dividend paid (542)     (542)    
Exercise of stock options and issuance of restricted stock units and awards (in Shares)   84,000        
Change in ownership of consolidated subsidiaries, net 2   (9)     11
Net income (loss) 746     712   34
Balance at end of period (in shares) at Mar. 31, 2023   181,605,000        
Balance at end of period at Mar. 31, 2023 $ 16,123 $ 2 14,502 967 (7) 659
Balance at beginning of period (in shares) at Dec. 31, 2022 179,840,797 179,841,000        
Balance at beginning of period at Dec. 31, 2022 $ 15,690 $ 2 14,213 801 (7) 681
Increase (Decrease) in Stockholders' Equity            
Net income (loss) $ 1,332          
Balance at end of period (in shares) at Jun. 30, 2023 179,221,318 179,219,000        
Balance at end of period at Jun. 30, 2023 $ 16,212 $ 2 14,187 1,372 (7) 658
Balance at beginning of period (in shares) at Mar. 31, 2023   181,605,000        
Balance at beginning of period at Mar. 31, 2023 16,123 $ 2 14,502 967 (7) 659
Increase (Decrease) in Stockholders' Equity            
Distribution equivalent rights payments (1)     (1)    
Stock-based compensation 22   22      
Cash paid for tax withholding on vested equity awards (in shares)   (18,000)        
Cash paid for tax withholding on vested equity awards (1)   (1)      
Repurchased shares for share buyback program (in Shares)   (2,427,000)        
Repurchased shares under buyback program (321)   (321)      
Repurchased units under buyback programs (23)         (23)
Distributions to non-controlling interest (25)         (25)
Dividend paid (150)     (150)    
Exercise of stock options and issuance of restricted stock units and awards (in Shares)   59,000        
Change in ownership of consolidated subsidiaries, net 2   (15)     17
Net income (loss) $ 586     556   30
Balance at end of period (in shares) at Jun. 30, 2023 179,221,318 179,219,000        
Balance at end of period at Jun. 30, 2023 $ 16,212 $ 2 $ 14,187 $ 1,372 $ (7) $ 658